Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance


AmerisourceBergen Corporation (NYSE: ABC) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $200 million in concurrence with Walgreens Boots Alliance's sale of AmerisourceBergen shares pursuant to Rule 144.

AmerisourceBergen intends to repurchase shares from Walgreens Boots Alliance at the price per share equal to the price in the Rule 144 sale. The concurrent share repurchase will be made under AmerisourceBergen's share repurchase program, and the repurchased shares will be held in treasury.

About AmerisourceBergen

AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. Our approximately 44,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 with more than $200 billion in annual revenue.


These press releases may also interest you

at 16:10
Pegasystems Inc. , the leading enterprise AI decisioning and workflow automation platform provider, released its financial results for the first quarter of 2024. "In Q1, we released Pega GenAI BlueprintTM, a revolutionary technology that massively...

at 16:10
Brightcove Inc. , the world's most trusted streaming technology company, today announced it will report its first quarter fiscal year 2024 results for the period ended March 31, 2024, after the U.S. financial markets close on May 8, 2024. In...

at 16:10
Acadia Pharmaceuticals Inc. today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets. Acadia's management team will also host a conference call and webcast on May 8,...

at 16:10
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May...

at 16:08
IBM today announced first-quarter 2024 earnings results. "We began the year with solid revenue and free cash flow growth, reflecting...

at 16:07
$6.4 billion acquisition adds suite of leading hybrid and multi-cloud lifecycle management products to help clients grappling with today's AI-driven application growth and complexity HashiCorp's capabilities to drive significant synergies across...



News published on and distributed by: